In‐Cheol Kang

1.8k total citations
77 papers, 1.4k citations indexed

About

In‐Cheol Kang is a scholar working on Molecular Biology, Immunology and Allergy and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, In‐Cheol Kang has authored 77 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 17 papers in Immunology and Allergy and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in In‐Cheol Kang's work include Cell Adhesion Molecules Research (15 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Advanced Biosensing Techniques and Applications (11 papers). In‐Cheol Kang is often cited by papers focused on Cell Adhesion Molecules Research (15 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Advanced Biosensing Techniques and Applications (11 papers). In‐Cheol Kang collaborates with scholars based in South Korea, United States and Japan. In‐Cheol Kang's co-authors include Doo‐Sik Kim, Moon Hi Han, Young‐Don Lee, Hyun‐Ja Jeong, Yoonsuk Lee, Soo‐Ik Chang, Kwang-Hoe Chung, Yangsoo Jang, Eun Kyoung Lee and John H. R. Maunsell and has published in prestigious journals such as Journal of Neuroscience, Nature Neuroscience and PLoS ONE.

In The Last Decade

In‐Cheol Kang

72 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
In‐Cheol Kang South Korea 25 792 254 241 159 151 77 1.4k
Karolina Krasinska United States 10 794 1.0× 82 0.3× 107 0.4× 121 0.8× 59 0.4× 12 1.3k
Naohide Hirashima Japan 26 1.3k 1.6× 151 0.6× 158 0.7× 60 0.4× 136 0.9× 103 2.1k
Charles F. Albright United States 28 2.2k 2.8× 72 0.3× 181 0.8× 47 0.3× 125 0.8× 66 3.1k
Tzeng‐Horng Leu Taiwan 26 1.1k 1.4× 303 1.2× 128 0.5× 50 0.3× 30 0.2× 56 2.1k
Manuel Simon Austria 23 1.3k 1.7× 47 0.2× 80 0.3× 200 1.3× 152 1.0× 29 2.5k
Philippe Rondé France 25 1.1k 1.4× 466 1.8× 84 0.3× 39 0.2× 73 0.5× 45 1.9k
Naichen Yu United States 21 1.2k 1.5× 69 0.3× 76 0.3× 176 1.1× 212 1.4× 27 2.4k
Antje Gohla Germany 22 1.4k 1.8× 217 0.9× 102 0.4× 35 0.2× 31 0.2× 37 2.2k
Hua Gao China 24 1.5k 1.9× 100 0.4× 87 0.4× 59 0.4× 350 2.3× 73 2.4k
Thierry Calmels France 20 939 1.2× 53 0.2× 88 0.4× 32 0.2× 73 0.5× 39 1.3k

Countries citing papers authored by In‐Cheol Kang

Since Specialization
Citations

This map shows the geographic impact of In‐Cheol Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by In‐Cheol Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites In‐Cheol Kang more than expected).

Fields of papers citing papers by In‐Cheol Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by In‐Cheol Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by In‐Cheol Kang. The network helps show where In‐Cheol Kang may publish in the future.

Co-authorship network of co-authors of In‐Cheol Kang

This figure shows the co-authorship network connecting the top 25 collaborators of In‐Cheol Kang. A scholar is included among the top collaborators of In‐Cheol Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with In‐Cheol Kang. In‐Cheol Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Ji‐Hye, et al.. (2025). Synergistic Effect of HAD-B1 and Osimertinib Against Gefitinib Resistant HCC827 Non-Small Cell Lung Cancer Cells. Integrative Cancer Therapies. 24. 1573622142–1573622142.
2.
3.
Quaia, Christian, In‐Cheol Kang, & Bruce G. Cumming. (2022). Pattern Motion Direction Is Encoded in the Population Activity of Macaque Area MT. Journal of Neuroscience. 42(50). 9372–9386. 3 indexed citations
4.
Yoo, Hwa‐Seung, et al.. (2019). The Extract of Cordyceps Militaris Inhibited the Proliferation of Cisplatin-Resistant A549 Lung Cancer Cells by Downregulation of H-Ras. Journal of Medicinal Food. 22(8). 823–832. 4 indexed citations
5.
Kim, Sunghoon, Bo-Kyung Park, Young Hwa Kim, et al.. (2018). Antidepressant Effect ofFraxinus rhynchophyllaHance Extract in a Mouse Model of Chronic Stress-Induced Depression. BioMed Research International. 2018. 1–12. 30 indexed citations
6.
Kang, In‐Cheol, et al.. (2018). The inhibitory effect of Cordycepin on the proliferation of cisplatin-resistant A549 lung cancer cells. Biochemical and Biophysical Research Communications. 498(3). 431–436. 21 indexed citations
7.
Park, Yu Mi, et al.. (2017). Nutriproteomic Analysis of Hwangmaemok-Induced Antiangiogenic Effect Using Antibody-Arrayed Protein Chip Assay. Journal of Medicinal Food. 20(6). 586–591. 2 indexed citations
8.
Jeong, Hyun‐Ja, Young‐Jin Choi, Minho Kim, et al.. (2011). Rosmarinic Acid, Active Component of Dansam-Eum Attenuates Ototoxicity of Cochlear Hair Cells through Blockage of Caspase-1 Activity. PLoS ONE. 6(4). e18815–e18815. 39 indexed citations
9.
Ramakrishna, Suresh, Bharathi Suresh, In‐Cheol Kang, & Kwang‐Hyun Baek. (2010). Polyclonal and Monoclonal Antibodies Specific for USP17, a Proapoptotic Deubiquitinating Enzyme. Hybridoma. 29(4). 311–319. 3 indexed citations
10.
Kang, Taehee, et al.. (2010). Atractylenolide III, a sesquiterpenoid, induces apoptosis in human lung carcinoma A549 cells via mitochondria-mediated death pathway. Food and Chemical Toxicology. 49(2). 514–519. 57 indexed citations
11.
Kim, Jae‐Joong, Taehee Kang, Ho-Jeong Na, et al.. (2010). Libanoridin inhibits the mast cell-mediated allergic inflammatory reaction. Immunopharmacology and Immunotoxicology. 32(2). 258–264. 5 indexed citations
12.
Choi, In-Young, Taehee Kang, Hyo‐Jin An, et al.. (2009). Synergistic Effects of KH-red Ginseng/chlorella on the Endurance Capacity and Immune Enhancing in Forced Swimming Tested Mice. Food Science and Biotechnology. 18(6). 1351–1357. 4 indexed citations
13.
Kang, In‐Cheol, et al.. (2009). Protein Chip-based Dipeptidyl Peptidase IV Assay System. BioChip Journal. 3(3). 249–253. 3 indexed citations
14.
Jeong, Hyun‐Ja, et al.. (2009). Activation of hypoxia-inducible factor-1 regulates human histidine decarboxylase expression. Cellular and Molecular Life Sciences. 66(7). 1309–1319. 43 indexed citations
15.
Kang, In‐Cheol, et al.. (2008). Induction of Apoptosis of β Cells of the Pancreas by Advanced Glycation End‐Products, Important Mediators of Chronic Complications of Diabetes Mellitus. Annals of the New York Academy of Sciences. 1150(1). 311–315. 71 indexed citations
16.
Kim, Ok-Tae, et al.. (2007). High Throughput Screening on Angiogenesis Inhibitor and Promoter of Medicinal Plants using a Protein Microarray Chip. Korean Journal of Medicinal Crop Science. 15(2). 89–94. 1 indexed citations
17.
Chang, Soo‐Ik, et al.. (2007). Detection Technology for Antibody-Antigen Interaction on ProteoChip using Quantum Dot. BioChip Journal. 1(2). 102–106. 2 indexed citations
18.
Lee, Eun‐Ok, Hyo‐Jeong Lee, Young‐Doo Park, et al.. (2004). Methylene chloride fraction of Scutellaria barbata induces apoptosis in human U937 leukemia cells via the mitochondrial signaling pathway. Clinica Chimica Acta. 348(1-2). 41–48. 55 indexed citations
19.
Lee, Do Hyung, et al.. (2002). Inhibitory Effects of Salmosin, a Disintegrin, on Posterior Capsular Opacification in vitro and in vivo. Experimental Eye Research. 74(5). 585–594. 27 indexed citations
20.
Kang, In‐Cheol & Doo‐Sik Kim. (1998). Analysis of the Potent Platelet Glycoprotein IIb-IIIa Antagonist from Natural Sources. BMB Reports. 31(5). 515–518. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karolina Krasinska Breakdown of academic impact, for papers by Naohide Hirashima Breakdown of academic impact, for papers by Charles F. Albright Breakdown of academic impact, for papers by Tzeng‐Horng Leu Breakdown of academic impact, for papers by Manuel Simon Breakdown of academic impact, for papers by Philippe Rondé Breakdown of academic impact, for papers by Naichen Yu Breakdown of academic impact, for papers by Antje Gohla Breakdown of academic impact, for papers by Hua Gao Breakdown of academic impact, for papers by Thierry Calmels
Rankless by CCL
2026